FDA takes first step toward greater regulatory certainty around nanotechnology
The U.S. Food and Drug Administration today released draft guidance to provide regulated industries with greater certainty about the use of nanotechnology, which generally involves materials made up of particles that are at least one billionth of a meter in size. The guidance outlines the agency s view on whether regulated products contain nanomaterials or involve the application of nanotechnology.